US FDA approves Syndax's blood cancer drug
The U.S. Food and Drug Administration on Friday approved Syndax Pharmaceuticals' drug for the treatment of adult and ...
In RFK Jr., drugmakers face an antagonist with regulatory power
Anxious and bewildered, some drugmakers are reaching out to their lobbyists about how Robert Kennedy’s pending nomination ...
Why the FDA Wants TV Drug Ads to Use Simpler Words and Lose the Distractions
Clear descriptions of potential risks and side effects will be required under rules that go into effect Nov. 20, even as the ...
Monthly Prescribing Reference18d
Hemoglobin Elevating Agent Gets Orphan Drug Status for Sickle Cell Disease
The hemoglobin elevating agent is being developed for the treatment of anemia associated with multiple diseases.
CBS News8d
FDA to pull common but ineffective cold medicine from market
The Food and Drug Administration announced Wednesday that it would seek to pull a widely used ingredient in cough and cold medicines from the market, after the agency's scientists concluded that ...
Business Insider23d
FDA Accepts New Drug Application and Grants Priority Review for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent
today announces that the United States (U.S.) Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for TLX101-CDx (Pixclara® 1), an agent for the imaging of glioma.
Spa owner made nearly $1 million injecting clients with fake Botox and filler, feds say
Fadanelli is accused of lying to clients and employees about being a registered nurse and performing thousands of injections ...
USA Today29d
Injectable drug to ease advanced Parkinson's disease symptoms approved by FDA
The Food and Drug Administration approved a drug produced by AbbVie for the treatment of late stage Parkinsons disease the company announced Thursday. The regulator approved Vyalev, also known as ...